ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/04/19 | 1,936 | 1,937 | 1,918 | 1,929 | +7 | +0.4% | 67,300 |
2019/04/18 | 1,947 | 1,952 | 1,916 | 1,922 | -48 | -2.4% | 134,800 |
2019/04/17 | 1,980 | 1,980 | 1,953 | 1,970 | -14 | -0.7% | 88,600 |
2019/04/16 | 1,990 | 2,005 | 1,981 | 1,984 | -14 | -0.7% | 80,000 |
2019/04/15 | 1,988 | 2,000 | 1,974 | 1,998 | +34 | +1.7% | 78,100 |
2019/04/12 | 1,974 | 1,977 | 1,943 | 1,964 | -12 | -0.6% | 73,300 |
2019/04/11 | 1,985 | 1,992 | 1,964 | 1,976 | -4 | -0.2% | 91,100 |
2019/04/10 | 1,957 | 1,984 | 1,945 | 1,980 | +11 | +0.6% | 128,400 |
2019/04/09 | 1,986 | 1,986 | 1,951 | 1,969 | -6 | -0.3% | 99,600 |
2019/04/08 | 1,985 | 1,990 | 1,965 | 1,975 | -9 | -0.5% | 61,100 |
2019/04/05 | 1,985 | 1,997 | 1,977 | 1,984 | +8 | +0.4% | 76,100 |
2019/04/04 | 1,961 | 1,980 | 1,953 | 1,976 | +15 | +0.8% | 52,400 |
2019/04/03 | 1,950 | 1,965 | 1,933 | 1,961 | +13 | +0.7% | 52,300 |
2019/04/02 | 1,971 | 1,980 | 1,942 | 1,948 | -13 | -0.7% | 108,600 |
2019/04/01 | 1,935 | 1,965 | 1,932 | 1,961 | +48 | +2.5% | 106,200 |
2019/03/29 | 1,907 | 1,916 | 1,901 | 1,913 | +14 | +0.7% | 83,100 |
2019/03/28 | 1,889 | 1,904 | 1,861 | 1,899 | -7 | -0.4% | 150,600 |
2019/03/27 | 1,903 | 1,911 | 1,892 | 1,906 | +13 | +0.7% | 121,200 |
2019/03/26 | 1,858 | 1,896 | 1,851 | 1,893 | +44 | +2.4% | 245,100 |
2019/03/25 | 1,862 | 1,868 | 1,844 | 1,849 | -30 | -1.6% | 193,100 |
2019/03/22 | 1,901 | 1,901 | 1,871 | 1,879 | -32 | -1.7% | 165,500 |
2019/03/20 | 1,911 | 1,928 | 1,903 | 1,911 | -6 | -0.3% | 111,100 |
2019/03/19 | 1,923 | 1,923 | 1,887 | 1,917 | -11 | -0.6% | 109,800 |
2019/03/18 | 1,900 | 1,928 | 1,892 | 1,928 | +43 | +2.3% | 113,300 |
2019/03/15 | 1,887 | 1,895 | 1,873 | 1,885 | +6 | +0.3% | 157,900 |
2019/03/14 | 1,880 | 1,884 | 1,864 | 1,879 | -1 | -0.1% | 123,500 |
2019/03/13 | 1,888 | 1,904 | 1,866 | 1,880 | -14 | -0.7% | 107,400 |
2019/03/12 | 1,887 | 1,897 | 1,872 | 1,894 | +19 | +1% | 130,700 |
2019/03/11 | 1,876 | 1,879 | 1,857 | 1,875 | -1 | -0.1% | 105,900 |
2019/03/08 | 1,895 | 1,902 | 1,873 | 1,876 | -46 | -2.4% | 123,500 |
2019/03/07 | 1,919 | 1,924 | 1,905 | 1,922 | -9 | -0.5% | 102,400 |
2019/03/06 | 1,932 | 1,936 | 1,914 | 1,931 | -1 | -0.1% | 101,200 |
2019/03/05 | 1,912 | 1,932 | 1,893 | 1,932 | +11 | +0.6% | 150,300 |
2019/03/04 | 1,930 | 1,939 | 1,914 | 1,921 | +13 | +0.7% | 107,600 |
2019/03/01 | 1,896 | 1,912 | 1,882 | 1,908 | +9 | +0.5% | 77,400 |
2019/02/28 | 1,887 | 1,923 | 1,867 | 1,899 | +6 | +0.3% | 89,700 |
2019/02/27 | 1,851 | 1,900 | 1,846 | 1,893 | +39 | +2.1% | 118,100 |
2019/02/26 | 1,860 | 1,865 | 1,842 | 1,854 | -9 | -0.5% | 82,600 |
2019/02/25 | 1,887 | 1,887 | 1,861 | 1,863 | -14 | -0.7% | 84,200 |
2019/02/22 | 1,893 | 1,895 | 1,862 | 1,877 | -31 | -1.6% | 105,800 |
2019/02/21 | 1,911 | 1,920 | 1,886 | 1,908 | +9 | +0.5% | 98,400 |
2019/02/20 | 1,908 | 1,912 | 1,892 | 1,899 | -11 | -0.6% | 74,500 |
2019/02/19 | 1,918 | 1,918 | 1,898 | 1,910 | -9 | -0.5% | 54,400 |
2019/02/18 | 1,934 | 1,934 | 1,905 | 1,919 | +25 | +1.3% | 68,000 |
2019/02/15 | 1,915 | 1,916 | 1,880 | 1,894 | -21 | -1.1% | 56,300 |
2019/02/14 | 1,915 | 1,928 | 1,906 | 1,915 | ±0 | ±0% | 76,600 |
2019/02/13 | 1,935 | 1,946 | 1,913 | 1,915 | -10 | -0.5% | 56,600 |
2019/02/12 | 1,908 | 1,926 | 1,901 | 1,925 | +25 | +1.3% | 63,300 |
2019/02/08 | 1,889 | 1,903 | 1,860 | 1,900 | -6 | -0.3% | 181,200 |
2019/02/07 | 1,920 | 1,920 | 1,893 | 1,906 | -14 | -0.7% | 128,000 |
1551~
1600
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム